ADMA Biologics
Manufacturing · New Jersey, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
465 State Rt 17, Ramsey, New Jersey, 074...Phone Number
(201) 478-5552Website
www.admabiologics.comRevenue
$509.9 MillionStock Symbol
ADMAIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
1
1
1
1
1
About ADMA Biologics
Founded in 2004, ADMA Biologics is a commercial biopharmaceutical company that focuses on manufacturing, marketing, and developing products for immunodeficient patients at risk for infection. The company is headquartered in Ramsey, New Jersey.Explore more
ADMA Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ADMA Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ADMA Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ADMA Biologics has new funding data
Earning: See what the market has to say on ADMA Biologics recently announced quarterly report
Product Launch: Get notified when ADMA Biologics launches new products
Website visits: Recent activity has been detected on your website
Check out if ADMA Biologics is spiking on competitors!
Check if ADMA Biologics has recently received funding, and reach out quickly before it becomes old news!
Click to see if ADMA Biologics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at ADMA Biologics
Recommended Actions
Find VP level buyers at ADMA Biologics
Find 2 more new buyers
Compare Similar Companies to ADMA Biologics
Compare insights from companies similar to ADMA Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ADMA Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ADMA Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ADMA Biologics.
ADMA Biologics financials insights
Gather financial insights about ADMA Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$15M
Corporate Investment
$5M
2015
Stock Offering
$10.3M
Debt
$21M
2016
Stock Offering
$14.1M
Debt
$4M
2017
Debt
$30M
Stock Offering
$39.1M
2018
Stock Offering
$40M
2019
Stock Offering
$51.8M
2020
Stock Offering
$82.3M
Debt
$100M
ADMA Biologics Tech Stack
A closer look at the technologies used by ADMA Biologics
Most Recent Scoops
Pain Point
Pain Point, Lawsuits, Legal Affairs
Person-Based
Lawsuits, Legal Affairs, Finance, Financial Transactions
Person-Based
Lawsuits, Legal Affairs, Revenue Operations
Person-Based
Earnings, Lawsuits, Legal Affairs, Finance
Person-Based
Audit, Board of Directors, Finance
ADMA Biologics News & Media
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
ADMA Biologics (ADMA) Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud LawsuitADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BENSALEM, Pa., July 21, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA). IF YOU ARE AN INVESTOR...ADMA UPCOMING DEADLINE: SueWallSt Alerts ADMA BIOLOGICS, INC. Stockholders of Securities Class Action
Wall Street's reassessment of ADMA Biologics accelerated after a short-seller report alleged that the company's reported 20% ASCENIV revenue growth was entirely fictitious, driven by channel stuffing that masked a 3% decline. Wall Street's reassessment of ADMA Biologics accelerated after a short-seller report alleged that the company's reported 20% ASCENIV revenue growth was entirely fictitious, driven by channel stuffing that masked a 3% decline.ADMA Lawsuit Notice: ADMA Biologics Channel Stuffing Allegations and 29% Stock Drop Trigger Securities Fraud Class Action
A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. NEW YORK, July 21, 2026 /PRNewswire/ -- Leading securities law firm...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ADMA Biologics
Sign Up For FreeTo access detailed company insights
Founded in 2004, ADMA Biologics is a commercial biopharmaceutical company that focuses on manufacturing, marketing, and developing products for immunodeficient patients at risk for infection. The company is headquartered in Ramsey, New Jersey.... Read More
